Lower access to risk stratification tests and drugs, and worse survival of chronic lymphocytic leukaemia patients treated in public as compared to private hospitals in Brazil: A retrospective analysis of the Brazilian registry of chronic lymphocytic leukaemia-Reference-Cited by-同舟云学术

Lower access to risk stratification tests and drugs, and worse survival of chronic lymphocytic leukaemia patients treated in public as compared to private hospitals in Brazil: A retrospective analysis of the Brazilian registry of chronic lymphocytic leukaemia

Published:2022-05-06 Issue:3 Volume:3 Page:698-706
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Pfister Verena¹²^ORCID,Marques Fernanda de Morais¹²³,Parra Flavia²,Yamamoto Mihoko¹,Gonçalves Matheus Vescovi¹,Perobelli Leila³,Buccheri Valeria⁴^ORCID,Bandeira Raphael⁴,Fortier Sergio⁵,Azevedo Alita⁶,Santucci Rodrigo⁷,Bellesso Marcelo⁷,Fogliatto Laura⁸,Ribeiro Glaciano⁹,Lopes Germison Silva¹⁰,Ikoma Maura¹¹,Figueiredo Vera P.¹²,Metze Irene Gyongyver H Lorand¹³^ORCID,Chiattone Carlos Sérgio⁵¹⁴,Arrais‐Rodrigues Celso¹²¹⁵

Affiliation:

1. Escola Paulista de Medicina /Universidade Federal de São Paulo, UNIFESP São Paulo Brazil

2. Brazilian Registry of CLL – Associação Brasileira de Hematologia e Hemoterapia Hemoterapia Brazil

3. Hospital Brigadeiro São Paulo Brazil

4. ICESP Faculdade de Medicina da USP São Paulo Brazil

5. Santa Casa de São Paulo São Paulo Brazil

6. HEMOPE Recife Brazil

7. Hemomed São Paulo Brazil

8. Hospital das Clínicas de Porto Alegre Porto Alegre Brazil

9. Universidade Federal de Minas Gerais Belo Horizonte Brazil

10. Universidade Federal do Ceará Fortaleza Brazil

11. Hospital Amaral Carvalho Jaú Brazil